Madison, Wis.-based UW Health Kids and Milwaukee-based Children’s Wisconsin are forming a joint venture to expand access to pediatric cardiac care.
Category: Static
CMS partners with 2 companies on sickle cell therapies
CMS has reached agreements with bluebird bio and Vertex Pharmaceuticals for their FDA-approved gene therapies for sickle cell disease — Casgevy and Lyfgenia, respectively.
5 clinical, allied health roles with highest turnover
Hospital staff turnover improved slightly in 2023 but remained a significant challenge for certain clinical roles, according to the American Hospital Association’s 2025 Environmental Scan report released Dec. 3.
Trinity gets $4B after split with Florida system
Livonia, Mich.-based Trinity Health returned to the black in fiscal year 2024 with an operating income of $68.4 million (0.3% margin) and received a $4 billion financial boost from its disaffiliation of BayCare Health System.
Florida system plans 2 new freestanding EDs
Hollywood, Fla.-based Memorial Healthcare System plans to develop two new freestanding emergency departments.
McLaren's annual operating margin drops 20% amid higher labor, supply costs
Grand Blanc, Mich.-based McLaren Health Care reported $80.1 million (1.2% margin) in operating income for the fiscal year ending Sept. 30, a 20.8% drop from the $101.1 million operating gain (1.5% margin) posted in the previous fiscal year.
Encompass awarded 43% of profits from former officers' new venture
The Delaware Court of Chancery ruled in favor of Birmingham, Ala.-based Encompass Health and its home health and hospice division, Enhabit, in a lawsuit against two private equity firms and three former Encompass officers who now run home health and ho…
ChristianaCare plans Aston healthcare campus
Newark, Del.-based ChristianaCare plans to open a new healthcare campus in Aston, Pa., featuring a neighborhood hospital and a health center.
California hospital hit by network disruption
PIH Health, based in Whittier, Calif., is experiencing a network disruption that is affecting its operations, KABC reported Dec. 4.
Mark Cuban defends his disruption status
Experts in healthcare and the pharmaceutical industry have questioned Mark Cuban’s ability to puncture high-priced medicines. In a 90-minute fireside chat with one of his critics, Mr. Cuban said his company has “truly changed the game.”
